1-5 of 5
Nichola Cooper, MA MD MRCP FRCPath
Close
Sort by
Journal Articles

Characterizing the United Kingdom Congenital Thrombotic Thrombocytopenic Purpura Population

Ferras Alwan, MBBS, Chiara Vendramin, Ri Liesner, Tina Dutt, Amanda Clark, Jayashree Motwani, Will Lester, Vickie McDonald, Rachel Rayment, Nichola Cooper, MA, MD MRCP, FRCPath, Richard Gooding, Hamish Lyall, Tina Biss, MD, Joost van Veen, Henry G Watson, John-Paul Westwood, Mari Thomas, Marie Scully
Journal: Blood
Blood (2017) 130 (Supplement 1): 3616.
https://doi.org/10.1182/blood.V130.Suppl_1.3616.3616
Published: 2017
Journal Articles

Long-Term Maintenance of Platelet Responses in Adult Patients with Persistent/Chronic Immune Thrombocytopenia Treated with Fostamatinib: 1-Year Efficacy and Safety Results

James B. Bussel, MD, Donald M Arnold, MD, Nichola Cooper, MA, MD MRCP, FRCPath, Alhossain A Khalafallah, MD, Michael Boxer, MD, Darla Liles, MD, Waleed Ghanima, MD PhD, Keith McCrae, MD, Hany Zayed, Benoit Cadieux, PhD, Anne-Marie Duliege, MDMS
Journal: Blood
Blood (2017) 130 (Supplement 1): 16.
https://doi.org/10.1182/blood.V130.Suppl_1.16.16
Published: 2017
Journal Articles

Eltrombopag (ELT) Reverses Iron Mediated Suppression of Insulin Secretion in Pancreatic Cells By Chelating Iron and Decreasing ROS

Evangelia Vlachodimitropoulou Koumoutsea, MBBS, Pimpisid Koonyosying, BSc, John B. Porter, BA MB BChir MRCP(Path) FRCP(Path) MD, Nichola Cooper, MA, MD MRCP, FRCPath, Bethan Psaila, Martha Sola-Visner, MD
Journal: Blood
Blood (2016) 128 (22): 1278.
https://doi.org/10.1182/blood.V128.22.1278.1278
Published: 2016
Journal Articles

Thrombopoietic Agonists Show Efficacy in ITP Related to Allogeneic Stem Cell Transplantation,

Emma M O'Donovan, MBBS BSc MRCP MRCPath, Katy Rezvani, MBBS, PhD, MRCP, FRCPath, Jeremy Sargent, MD, MRCP, FRCPath, Deborah Richardson, MD, FRCP, FRCPath, MA, MBBChir, Hannah Tharmalingam, Paul Veys, MD MRCP FRCPath, Jane F Apperley, MBChB, MD, FRCP, FRCPath, Nichola Cooper, MA MD MRCP FRCPath
Journal: Blood
Blood (2011) 118 (21): 3292.
https://doi.org/10.1182/blood.V118.21.3292.3292
Published: 2011
Journal Articles

Final Results From a Phase II Trial with the First in Class Recombinant Polyclonal Antibody Product Rozrolimupab in Primary Immune Thrombocytopenia

Tadeusz Robak, Jacek Trelinski, Mario von Depka Prondzinski, Aristoteles Giagounidis, Chantal Doyen, MD, Ann Janssens, Mayte Álvarez Román, MD, Javier Loscertales Pueyo, Isidro Jarque Ramos, Javier Loscertales, Gloria Pérez Rus, Andrzej Hellmann, MD, Wieslaw Wiktor-Jedrzejczak, MD, PhD, Kazimierz Kuliczkowski, Lana Golubovic, Dusica Celeketic, Andrei Cucuianu, Emanuil Gheorghita, Lazaroiu Mihaela, Dina Attias, Ofer Shpilberg, MD, MPH, Elena Karyagina, Kateryna Vilchevska, Kalinina Svetlana, Nichola Cooper, MA MD MRCP FRCPath, Kate Talks, Mukyaprana Prabhu, Sripada V.S.S Prasad, T. P. Raghava Bharadwaj, Mimi Folden Flensburg, Jorgen Petersen, MD, PhD, Jerzy Windyga
Journal: Blood
Blood (2011) 118 (21): 527.
https://doi.org/10.1182/blood.V118.21.527.527
Published: 2011